|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global Cancer Statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fujimoto K, Yamada Y, Okajima E, Kakizoe
T, Sasaki H, Sugimura T and Terada M: Frequent association of p53
gene mutation in invasive bladder cancer. Cancer Res. 52:1393–1398.
1992.PubMed/NCBI
|
|
3
|
Kiriluk KJ, Prasad SM, Patel AR, Steinberg
GD and Smith ND: Bladder cancer risk from occupational and
environmental exposures. Urol Oncol. 30:199–211. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Williams SG and Stein JP: Molecular
pathways in bladder cancer. Urol Res. 32:373–385. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lin HY, Huang CH, Wu WJ, Chou YH, Fan PL
and Lung FW: Mutation of the p53 tumor suppressor gene in
transitional cell carcinoma of the urinary tract in Taiwan.
Kaohsiung J Med Sci. 21:57–64. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Berggren P, Steineck G, Adolfsson J,
Hansson J, Jansson O, Larsson P, Sandstedt B, Wijkström H and
Hemminki K: p53 mutations in urinary bladder cancer. Br J Cancer.
84:1505–1511. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Greenblatt MS, Bennett WP, Hollstein M and
Harris CC: Mutations in the p53 tumor suppressor gene: Clues to
cancer etiology and molecular pathogenesis. Cancer Res.
54:4855–4878. 1994.PubMed/NCBI
|
|
8
|
Romero JG Lorenzo, Sánchez AS Salinas,
Bachs JM Giménez, Sánchez F Sánchez, Martínez J Escribano, Millán
IR Hernández, Martín M Segura and Rodríguez JA Virseda: p53 Gene
mutations in superficial bladder cancer. Urol Int. 73:212–218.
2004. View Article : Google Scholar
|
|
9
|
Chen GF, Chan FL, Hong BF, Chan LW and
Chan PS: Mitochondrial DNA mutations in chemical carcinogen-induced
rat bladder and human bladder cancer. Oncol Rep. 12:463–472.
2004.PubMed/NCBI
|
|
10
|
Wada T, Tanji N, Ozawa A, Wang J,
Shimamoto K, Sakayama K and Yokoyama M: Mitochondrial DNA mutations
and 8-hydroxy-2′-deoxyguanosine Content in Japanese patients with
urinary bladder and renal cancers. Anticancer Res. 26:3403–3408.
2006.PubMed/NCBI
|
|
11
|
Dasgupta S, Hoque MO, Upadhyay S and
Sidransky D: Mitochondrial cytochrome B gene mutation promotes
tumor growth in bladder cancer. Cancer Res. 68:700–706. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Carew JS and Huang P: Mitochondrial
defects in cancer. Mol Cancer. 1:92002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chang SC, Lin PC, Yang SH, Wang HS, Liang
WY and Lin JK: Mitochondrial D-loop mutation is a common event in
colorectal cancers with p53 mutations. Int J Colorectal Dis.
24:623–628. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gochhait S, Bhatt A, Sharma S, Singh YP,
Gupta P and Bamezai RN: Concomitant presence of mutations in
mitochondrial genome and p53 in cancer development-a study in north
Indian sporadic breast and esophageal cancer patients. Int J
Cancer. 123:2580–2586. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ghaffarpour M, Mahdian R, Fereidooni F,
Kamalidehghan B, Moazami N and Houshmand M: The mitochondrial
ATPase6 gene is more susceptible to mutation than the ATPase8 gene
in breast cancer patients. Cancer Cell Int. 14:212014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Prior SL, Griffiths AP and Lewis PD: A
study of mitochondrial DNA D-loop mutations and p53 status in
nonmelanoma skin cancer. Br J Dermatol. 161:1067–1071. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhou S, KAchap S and Singh KK:
Mitochondrial impairment in p53-deficient human cancer cells.
Mutagenesis. 18:287–292. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shipman R, Schraml P, Moch H, Colombi M,
Sauter G, Mihatsch M and Ludwig C: p53 protein accumulation and p53
gene alterations (RFLP, VNTR and p53 gene mutations) in
non-invasive versus invasive human transitional bladder cancer. Int
J Oncol. 10:801–806. 1997.PubMed/NCBI
|
|
19
|
Sidransky D, Von Eschenbach A, Tsai YC,
Jones P, Summerhayes I, Marshall F, Paul M, Green P, Hamilton SR,
Frost P, et al: Identification of p53 gene mutations in bladder
cancers and urine samples. Science. 252:706–709. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Phillips HA, Howard GC and Miller WR: p53
mutations as a marker of malignancy in bladder washing samples from
patients with bladder cancer. Br J Cancer. 82:136–141.
2000.PubMed/NCBI
|
|
21
|
Kindelán J Álvarez, López-Beltrán A and
Tapia MJ Requena: Molecular biology in bladder cancer. Actas Urol
Esp. 24:604–625. 2000.(In Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lianes P: Biología Molecular del Cáncer de
VejigaTumores Vesicales Superficiales. Vicente J, Chéchile G and
Salvador J: Acción Médica; Madrid: pp. 47–60. 2000, (In
Spanish).
|
|
23
|
Akouchekian M, Houshmand M, Akbari MH,
Kamalidehghan B and Dehghan M: Analysis of mitochondrial ND1 gene
in human colorectal cancer. J Res Med Sci. 16:50–55.
2011.PubMed/NCBI
|
|
24
|
Petros JA, Baumann AK, Ruiz-Pesini E, Amin
MB, Sun CQ, Hall J, Lim S, Issa MM, Flanders WD, Hosseini SH, et
al: mtDNA mutations increase tumorigenicity in prostate cancer.
Proc Natl Acad Sci USA. 102:719–724. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Blakely EL, Mitchell AL, Fisher N, Meunier
B, Nijtmans LG, Schaefer AM, Jackson MJ, Turnbull DM and Taylor RW:
A mitochondrial Cytochrome b mutation causing severe respiratory
chain enzyme deficiency in human and yeast. FEBS J. 272:3583–3592.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jonckheere AII, Smeitink JA and Rodenburg
RJ: Mitochondrial ATP synthase: architecture, function and
pathology. J Inherit Metab Dis. 35:211–225. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Czarnecka AM, Kukwa W, Krawczyk T, Scinska
A, Kukwa A and Cappello F: Mitochondrial DNA mutations in cancer -
from bench to bedside. Front Biosci (Landmark Ed). 15:437–460.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Amuthan G, Biswas G, Zhang SY,
Klein-Szanto A, Vijayasarathy C and Avadhani NG:
Mitochondria-to-nucleus stress signaling induces phenotypic
changes, tumor progression and cell invasion. Embo J. 20:1910–1920.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Matsuyama S, Xu Q, Velours J and Reed JC:
The Mitochondrial F0F1-ATPase proton pump is required for function
of the proapoptotic protein Bax in yeast and mammalian cells. Mol
Cell. 1:327–336. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Guney AI, Ergec DS, Tavukcu HH, Koc G,
Kirac D, Ulucan K, Javadova D and Turkeri L: Detection of
mitochondrial DNA mutations in nonmuscle invasive bladder cancer.
Genet Test Mol Biomarkers. 16:672–678. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Simonnet H, Alazard N, Pfeiffer K, Gallou
C, Béroud C, Demont J, Bouvier R, Schägger H and Godinot C: Low
mitochondrial respiratory chain content correlates with tumor
aggressiveness in renal cell carcinoma. Carcinogenesis. 23:759–768.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Meierhofer D, Mayr JA, Foetschl U, Berger
A, Fink K, Schmeller N, Hacker GW, Hauser-Kronberger C, Kofler B
and Sperl W: Decrease of mitochondrial DNA content and energy
metabolism in renal cell carcinoma. Carcinogenesis. 25:1005–1010.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Achanta G, Sasaki R, Feng L, Carew JS, Lu
W, Pelicano H, Keating MJ and Huang P: Novel role of p53 in
maintaining mitochondrial genetic stability through interaction
with DNA Pol gamma. EMBO J. 24:3482–3492. 2005. View Article : Google Scholar : PubMed/NCBI
|
